GATA2 and Myelodysplasia: These observations indicate important opportunities for primary care providers and rheumatologists to consider GATA2 deficiency in patients presenting with musculoskeletal complaints, infections, myelodysplasia, autoimmune diseases, or lymphedema (Fig. 2).